A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBeijing Friendship Hospital
About this trial
A prospective cohort of papillary thyroid carcinoma(PTC), patients who received thermal ablation in our hospital since February 2023 was established as the study object. Preoperative and postoperative demographic data, ultrasonography, other relevant laboratory tests, and thyroid disease-related scales such as fatigue, depression, and stress were collected. The influencing factors of PTC recurrence were analyzed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients with pathologically proven PTC underwent ultrasound-guided percutaneous thermal ablation.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
No Intervention
Other interventionNo Intervention
Treatment groups
600 Participants
are divided into 1 treatment groupGroup A: No Intervention1 intervention
Trial outcomes
Primary outcomes
1
the recurrence of PTC
the recurrence of PTC during follow-up
Time frame
1 to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov